A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
1 other identifier
observational
200,000
1 country
45
Brief Summary
CR-HepB registry started in June 30,2012 to collect HBV cases from general hospitals or specialized hospitals for infectious diseases in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. The main criteria for registration is HBsAg-positivity more than 6 months, and these patients will receive followed-up visits every three to six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Longer than P75 for all trials
45 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2012
CompletedFirst Submitted
Initial submission to the registry
April 6, 2017
CompletedFirst Posted
Study publicly available on registry
April 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedNovember 6, 2017
November 1, 2017
10.5 years
April 6, 2017
November 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of liver-related events after antiviral therapy
Rates of cirrhosis,decompensation and hepatocellular carcinoma with or without antiviral therapy
10 years
Secondary Outcomes (2)
The HBV DNA undetectable rate with or without antiviral therapy
10 years
HBeAg loss and seroconversion rates with or without antiviral therapy
10 years
Other Outcomes (2)
HBsAg loss and seroconversion rates with or without antiviral therapy
10 years
Quality of life
10 years
Study Arms (7)
Immune tolerance phase
Immune tolerance phase is diagnosed based on the presence of high serum levels of HBV-DNA, hepatitis B e antigen (HBeAg), but normal or minimally elevated serum alanine aminotransferase (ALT), and normal liver or only minimal histological activity and scant fibrosis.
HBeAg positive CHB
HBeAg positive CHB is defined as those with HBsAg positive for more 6 months, HBeAg positive, high HBV DNA, elevated serum levels of ALT and histological activity.
HBeAg negative CHB
HBeAg negative CHB is defined as those with HBeAg negative, anti-HBe positive, lower serum HBV DNA levels and histological necroinflammation and fibrosis.
Inactive HBsAg carriers
Inactive HBsAg carriers was defined as those with HBsAg positive than 6 months, with low HBV DNA and persistently normal ALT, without evidence of cirrhosis.
Compensated cirrhosis
Diagnosis of compensated cirrhosis can be made if one of the following criteria was met: 1. by liver histology: Ishak fibrosis stage 5-6 or METAVIR F4. 2. endoscopy-proven gastroesophageal varices, afrter excluding non-cirrhotic portal hypertension. 3. at least 2 features of cirrhosis: 1. irregular liver surface, granular or nodular liver parenchyma, with or without splenomegaly (spleen thickness \> 4.0cm or \> 5 rib units) on ultrasound ,CT or MRI; 2. PLT\<100×109/L without other causes; 3. Serum album in\<35 g/L or INR\>1.3 or PT prolongs\>3s; 4. LSM\>13 kpa (ALT\<5×ULN).
Decompensated cirrhosis
Decompensated cirrhosis was diagnosed based on the presence of ascites, bleeding esophageal varices and/or hepatic encephalopathy in cirrhotic patients.
Hepatocellular carcinoma
Diagnosis of hepatocellular carcinoma(HCC)can be established when one of the following one of the following 2 criteria:(1)in cirrhotic patients with nodules of 1cm or larger with typical features of HCC ( arterial enhancement with washout in venous or delay phase) on 2 radiological studies or with 1 radiological study and elevation of serum AFP; or(2)histological evidence of HCC.
Eligibility Criteria
The registry is a multicentre and observational study enrolling patients with hepatitis B across China. The main criteria for patients registration within the system was HBsAg-positivity over a continuous six months. The core exclusion criteria are: 1) HCC patients for their treatment mainly depends on surgical operation and interventional therapy, but not the antiviral therapy; 2) patients who are unable or unwilling to provide informed consent. All potential subjects meeting enrollment criteria are offered the opportunity to participate.
You may qualify if:
- HBsAg-positivity over a continuous six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Friendship Hospitallead
- Beijing YouAn Hospitalcollaborator
- The First Hospital of Jilin Universitycollaborator
- Henan Provincial People's Hospitalcollaborator
- Beijing Ditan Hospitalcollaborator
- First Affiliated Hospital of Xinjiang Medical Universitycollaborator
- LanZhou Universitycollaborator
- The Second Affiliated Hospital of Chongqing Medical Universitycollaborator
- West China Hospitalcollaborator
- The Third People's Hospital of Taiyuancollaborator
- Hebei Medical University Third Hospitalcollaborator
- Shengjing Hospitalcollaborator
- Tianjin Third Central Hospitalcollaborator
- Peking University First Hospitalcollaborator
- Peking Union Medical College Hospitalcollaborator
- The Affiliated Hospital Of Southwest Medical Universitycollaborator
- Shanghai Public Health Clinical Centercollaborator
- Ruijin Hospitalcollaborator
- First Affiliated Hospital Xi'an Jiaotong Universitycollaborator
- Xiangya Hospital of Central South Universitycollaborator
- Beijing Tiantan Hospitalcollaborator
- Wuhan Universitycollaborator
- First Affiliated Hospital of Kunming Medical Universitycollaborator
- The Affiliated Hospital of Xuzhou Medical Universitycollaborator
- The Affiliated Hospital of Yanbian Universitycollaborator
- First Affiliated Hospital of Chongqing Medical Universitycollaborator
- The Fourth People's Hospital of Qinghai Provincecollaborator
- Weifang Medical Universitycollaborator
- Hunan Provincial People's Hospitalcollaborator
- The Second Hospital of Hebei Medical Universitycollaborator
- Xixi Hospital of Hangzhoucollaborator
- General Hospital of Ningxia Medical Universitycollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
- Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospitalcollaborator
- Peking University People's Hospitalcollaborator
- Nanfang Hospital, Southern Medical Universitycollaborator
- The Affiliated Hospital Of Guizhou Medical Universitycollaborator
- Guizhou Provincial People's Hospitalcollaborator
- Hainan General Hospitalcollaborator
- The Second Hospital of Shandong Universitycollaborator
- The First Affiliated Hospital of Shanxi Medical Universitycollaborator
- Fifth Hospital of Shijiazhuang Citycollaborator
- Yan'an University Affiliated Hospitalcollaborator
- Infectious Disease Hospital of Wuhaicollaborator
- Logistics University of Chinese People's Armed Police Forcescollaborator
- People's Hospital of Changji Hui Autonomous Prefecture,Xinjiangcollaborator
Study Sites (45)
Beijing Ditan Hospital
Beijing, Beijing Municipality, 100015, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100032, China
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100050, China
Beijing Youan Hospital
Beijing, Beijing Municipality, 100069, China
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Lanzhou University Second Hospital
Lanzhou, Gansu, 730030, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, 730099, China
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550004, China
Guizhou provincial people's hospital
Guiyang, Guizhou, China
Hainan General Hospital
Haikou, Hainan, 570311, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
The Fifth Hospital of Shijiazhuang
Shijiazhuang, Hebei, 050021, China
The Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050051, China
Henan Provincial People's Hospital
Zhengzhou, Henan, 450003, China
Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430071, China
Hunan Provincial People's Hospital
Changsha, Hunan, 410005, China
Xiangya Hospital Central South University
Changsha, Hunan, 410008, China
Infectious Disease Hospital of Wuhai
Wuhai, Inner Mongolia, 016099, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221006, China
First Hospital of Jilin University
Changchun, Jilin, 130021, China
The Affiliated Hospital of Yanbian University
Yanbian, Jilin, 133000, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 70004, China
The Second Hospital of Shandong University
Jinan, Shandong, 250033, China
Affiliated Hospital of Weifang Medical University
Weifang, Shandong, 261031, China
Shanghai Ruijin Hospital
Shanghai, Shanghai Municipality, 200025, China
Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, 201508, China
The First Affiliated Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
Taiyuan No.3 Hospital
Taiyuan, Shanxi, 030012, China
First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, 710061, China
Yanan University Affiliated Hospital
Yanan, Shanxi, 716000, China
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646099, China
Affiliated Hospital, Logistics University of People's Armed Police Force
Tianjin, Tianjin Municipality, 300163, China
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality, 610041, China
People's Hospital of Changji Hui Autonomous Prefecture,Xinjiang
Changji, Xinjiang, 831118, China
First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital
Ürümqi, Xinjiang, 830099, China
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650032, China
Xixi Hospital of Hangzhou
Hangzhou, Zhejiang, 310023, China
Related Publications (3)
You H, Kong Y, Hou J, Wei L, Zhang Y, Niu J, Han T, Ou X, Dou X, Shang J, Tang H, Xie Q, Ding H, Ren H, Xu X, Xie W, Liu X, Xu Y, Li Y, Li J, Chow SC, Zhuang H, Jia J. Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B. Sci Rep. 2016 Nov 28;6:37498. doi: 10.1038/srep37498.
PMID: 27892487BACKGROUNDZhang Y, Wang Y, Jiao S, Li S, Liu X, Li T, Qu Y. Nonlinear relationship between age and the risk of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis. BMC Infect Dis. 2025 Nov 21;25(1):1635. doi: 10.1186/s12879-025-12016-9.
PMID: 41272517DERIVEDShan S, Wei W, Kong Y, Niu J, Shang J, Xie W, Zhang Y, Ren H, Tang H, Ding H, Nan Y, Dou X, Han T, Xu X, Duan Z, Wei L, Hou J, Zhuang H, You H, Jia J; CR-Hepb Study Group, Beijing, China. China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B. Scand J Public Health. 2020 Mar;48(2):233-239. doi: 10.1177/1403494818772188. Epub 2018 May 1.
PMID: 29716439DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jidong Jia, Doctor
Beijing Friendship Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Liver Research Center
Study Record Dates
First Submitted
April 6, 2017
First Posted
April 11, 2017
Study Start
June 30, 2012
Primary Completion
December 31, 2022
Study Completion
December 31, 2025
Last Updated
November 6, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share